Treatment of Early Glottic cancer with Transoral Laser Microsurgery: An Australian Experience.

Carcinoma, Squamous cell Laryngeal neoplasms Laryngoscopy Laser therapy Radiotherapy Survival analysis

Journal

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
ISSN: 2231-3796
Titre abrégé: Indian J Otolaryngol Head Neck Surg
Pays: India
ID NLM: 9422551

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 05 05 2022
accepted: 07 12 2022
pmc-release: 01 06 2024
medline: 5 6 2023
pubmed: 5 6 2023
entrez: 5 6 2023
Statut: ppublish

Résumé

Early laryngeal carcinomas may be treated by transoral laser microsurgery (TLM) or external beam radiotherapy. We review our experience of surgical treatment of laryngeal pre-malignant and malignant lesions over the past 15 years in a high-volume head neck unit. A review of a prospective patient database of patients with laryngeal SCC, who were treated with CO 83 patients with a mean age of 67.7 (SD: 10.6) years underwent primary curative TLM for T1a/b SCC. 5-year overall survival was 93.2% (95%CI 86.9-100%), disease free survival was 86.0% (95%CI 78.1-94.6%), locoregional control was 91.2% (95%CI: 85.1-97.7%) and larynx preservation rate of 95.1% at 5 years. TLM is an excellent treatment modality for T1 early glottic SCC, with excellent locoregional control and disease-free survival. It is minimally invasive, outpatient-based, and cost-effective procedure preserving upper aerodigestive tract dysfunction for all activities of daily living.

Identifiants

pubmed: 37274960
doi: 10.1007/s12070-022-03392-8
pii: 3392
pmc: PMC10235397
doi:

Types de publication

Journal Article

Langues

eng

Pagination

661-667

Informations de copyright

© Crown 2022.

Déclaration de conflit d'intérêts

Authors wish to acknowledge no conflict of interest.

Références

Laryngoscope. 2013 Nov;123(11):2670-4
pubmed: 23553229
Eur Arch Otorhinolaryngol. 2015 Feb;272(2):413-8
pubmed: 25351502
Laryngoscope. 2011 Jan;121(1):116-34
pubmed: 21120828
Head Neck. 2011 Nov;33(11):1638-48
pubmed: 21990228
ORL J Otorhinolaryngol Relat Spec. 2011;73(6):336-42
pubmed: 22005723
Ann Otol Rhinol Laryngol. 1972 Dec;81(6):791-8
pubmed: 4636137
J Clin Oncol. 2018 Apr 10;36(11):1143-1169
pubmed: 29172863
Laryngoscope. 1984 Apr;94(4):488-94
pubmed: 6708692
Laryngoscope. 2003 Jan;113(1):68-76
pubmed: 12514385
Laryngoscope. 2018 Sep;128(9):2039-2053
pubmed: 29508408
Eur Arch Otorhinolaryngol. 2000;257(4):221-6
pubmed: 10867839
Head Neck. 2012 Jan;34(1):23-33
pubmed: 21374753
Laryngoscope Investig Otolaryngol. 2020 Jun 26;5(4):665-671
pubmed: 32864436
Ann Otol Rhinol Laryngol. 2003 Oct;112(10):904-11
pubmed: 14587984
Laryngoscope. 2002 Feb;112(2):370-4
pubmed: 11889399
Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):385-90
pubmed: 19380362
Ann Otol Rhinol Laryngol. 1994 Jan;103(1):28-30
pubmed: 8291856
Cancer Causes Control. 2002 Dec;13(10):957-64
pubmed: 12588092
Head Neck. 2016 Apr;38 Suppl 1:E987-90
pubmed: 26040665
Ann Otol Rhinol Laryngol. 1989 Feb;98(2):105-9
pubmed: 2916820
Clin Otolaryngol. 2013 Aug;38(4):306-12
pubmed: 23731781
Laryngoscope. 2013 Aug;123(8):1912-7
pubmed: 23606304
Eur Arch Otorhinolaryngol. 2000;257(4):227-31
pubmed: 10867840
Head Neck. 2005 Aug;27(8):733
pubmed: 15986477
Otolaryngol Head Neck Surg. 2005 Jun;132(6):857-61
pubmed: 15944555
Sci Rep. 2018 Aug 9;8(1):11900
pubmed: 30093659
Laryngoscope. 2004 Aug;114(8):1485-91
pubmed: 15280731
Curr Opin Otolaryngol Head Neck Surg. 2017 Jun;25(3):211-216
pubmed: 28277333
J Otolaryngol Head Neck Surg. 2009 Dec;38(6):603-12
pubmed: 19958721
Head Neck. 2012 Aug;34(8):1179-89
pubmed: 21965105
Ann Otol Rhinol Laryngol. 2001 Apr;110(4):312-8
pubmed: 11307905
J Otolaryngol Head Neck Surg. 2019 Sep 3;48(1):44
pubmed: 31481120
Head Neck. 1999 Dec;21(8):707-17
pubmed: 10562683
Medicine (Baltimore). 2015 Jul;94(29):e1169
pubmed: 26200618
Otolaryngol Head Neck Surg. 2010 Sep;143(3):331-6
pubmed: 20723767
Radiother Oncol. 1998 Aug;48(2):175-83
pubmed: 9783889
Head Neck. 2009 Jun;31(6):759-64
pubmed: 19260127
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Eur J Surg Oncol. 2008 Jun;34(6):692-8
pubmed: 17686606
Am J Otolaryngol. 1997 Nov-Dec;18(6):385-90
pubmed: 9395014
Otolaryngol Head Neck Surg. 2013 Dec;149(6):830-9
pubmed: 24013140

Auteurs

Navid Ahmadi (N)

Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW Australia.
Department of ENT, Westmead Hospital, Sydney, NSW Australia.
Faculty of Medicine, University of New South Wales, Sydney, NSW Australia.

Danielle Stone (D)

Crown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.

Murray Stokan (M)

Department of Anaesthetics, Westmead Hospital, Sydney, NSW Australia.

Hedley Coleman (H)

Crown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.
Douglass Hanly Moir Pathology, Sydney, NSW Australia.

Gillian Heller (G)

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW Australia.

Mark Smith (M)

Department of ENT, Westmead Hospital, Sydney, NSW Australia.

Faruque Riffat (F)

Department of ENT, Westmead Hospital, Sydney, NSW Australia.

Akshay Kudpaje (A)

Crown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.
Cytecare Cancer Hospitals, Bangalore, India.

Michael Veness (M)

Crown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.
Sydney Medical School, University of Sydney, Sydney, NSW Australia.

Carsten E Palme (CE)

Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW Australia.
Department of ENT, Westmead Hospital, Sydney, NSW Australia.
Sydney Medical School, University of Sydney, Sydney, NSW Australia.

Classifications MeSH